| CXHL1900214 | 509 | 509 | Active ingredient | Chemical Drugs(1) | New Drug Application | 2019-07-04 | 武汉恒信源药业有限公司 | Wuhan Hengxinyuan Pharmaceutical Co Ltd | In Review | 2019-07-02 | view |
| CXHL1900215 | 509胶囊 | 509 | Capsule | Chemical Drugs(1) | New Drug Application | 2019-07-04 | 武汉恒信源药业有限公司 | Wuhan Hengxinyuan Pharmaceutical Co Ltd | In Review | 2019-07-02 | view |
| CXHL1900216 | 509胶囊 | 509 | Capsule | Chemical Drugs(1) | New Drug Application | 2019-07-04 | 武汉恒信源药业有限公司 | Wuhan Hengxinyuan Pharmaceutical Co Ltd | In Review | 2019-07-02 | view |
| JXSL2300177 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Import Drug Application | 2023-10-11 | | | | | view |
| JXSB2400107 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Supplementary Application | 2024-07-31 | | Amgen Inc | | | view |
| JXSL2300063 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Import Drug Application | 2023-03-31 | | | | | view |
| JXSB2400004 | AMG 509 | AMG-509 | Injection | Biological Products(1) | Supplementary Application | 2024-01-17 | | Amgen Inc | | | view |
| JYHB1800442 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Supplementary Application | 2018-04-20 | Aragon Pharmaceuticals,Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2018-07-09 | view |
| JXHL1500251 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Import Drug Application | 2015-10-12 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2016-07-15 | view |
| JYHB1800441 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Supplementary Application | 2018-04-20 | Aragon Pharmaceuticals,Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2018-07-09 | view |
| JXHL1500207 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Import Drug Application | 2015-08-24 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2016-07-15 | view |
| JXHL1500006 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Import Drug Application | 2015-03-27 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2016-03-28 | view |
| JYHB1800440 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Supplementary Application | 2018-04-20 | Aragon Pharmaceuticals,Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2018-07-09 | view |
| JXHL1400410 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Import Drug Application | 2015-03-27 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2016-03-28 | view |
| JYHB1800439 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Supplementary Application | 2018-04-20 | Aragon Pharmaceuticals,Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2018-07-09 | view |
| JYHB1601050 | ARN-509片 | apalutamide | Tablet | Chemical Drugs | Supplementary Application | 2016-08-19 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2016-12-30 | view |
| JXHL1400081 | ARN-509胶囊 | apalutamide | Capsule | Chemical Drugs | Import Drug Application | 2014-03-25 | Aragon Pharmaceuticals, Inc. | Aragon Pharmaceuticals Inc | Certificate Issued | 2015-05-21 | view |
| JXHL2300194 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2023-08-22 | | | | | view |
| JXHB2400006 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Supplementary Application | 2024-01-04 | | Boehringer Ingelheim International GmbH | | | view |
| JXHL2101224 | BI685509片 | Avenciguat | Tablet | Chemical Drugs(1) | Import Drug Application | 2021-10-27 | | | | | view |
